Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07632794

Artificial Intelligence Assisting Transcatheter Mitral Edge-to-Edge Repair

This multicenter, retrospective study develops and validates artificial intelligence (AI)-based semantic segmentation algorithms for intraprocedural transesophageal echocardiography (TEE) during Transcatheter Mitral Edge-to-Edge Repair (TEER). Using pooled imaging data from multiple high-volume structural heart centers, the study aims to automate recognition of mitral leaflets and MitraClip components, measure leaflet insertion length in real time, and display clip position and orientation. Algorithm performance will be benchmarked against expert manual annotations.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, China

Loading trial locations.

About this study

Transcatheter Mitral Edge-to-Edge Repair (TEER) with the MitraClip device is an established minimally invasive treatment for patients with severe mitral regurgitation who are at high surgical risk. The success of TEER relies heavily on real-time transesophageal echocardiography (TEE) to guide precise clip positioning and leaflet capture. However, intraoperative image interpretation remains highly dependent on operator experience, and variability in image quality, patient anatomy, and the dynamic nature of cardiac structures continue to challenge procedural standardization across centers.

This multicenter, retrospective imaging study evaluates whether artificial intelligence (AI)-based semantic segmentation can automate the recognition of mitral valve anatomy and MitraClip device components on intraprocedural TEE images. Previously acquired TEE imaging from adult patients who underwent TEER at multiple participating high-volume structural heart centers will be pooled and analyzed. All data are derived from routine clinical care, and only patients with appropriate consent for research use of their clinical and imaging data are included.

The study has three objectives: (1) to develop deep learning models that automatically segment the anterior and posterior mitral leaflets and the MitraClip grippers and arms; (2) to automate real-time measurement of leaflet insertion length during the grasping process; and (3) to integrate three-dimensional imaging with intelligent tracking to display clip position and orientation. By drawing on a multicenter dataset, the study aims to improve the generalizability and robustness of the resulting models across diverse imaging environments, operator practices, and patient anatomies. Algorithm performance will be benchmarked against expert manual annotations using established image segmentation metrics.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients (≥18 years of age) at the time of the index procedure
  • Confirmed diagnosis of degenerative or functional mitral regurgitation
  • Underwent Transcatheter Mitral Edge-to-Edge Repair (TEER) with the MitraClip device at one of the participating centers
  • Intraprocedural transesophageal echocardiographic (TEE) imaging available, complete, and of sufficient quality to support semantic segmentation and real-time measurement analyses
  • Appropriate consent for research use of clinical and imaging data, as per the policy of each participating center

Exclusion criteria

  • Incomplete or poor-quality intraprocedural TEE imaging unsuitable for accurate segmentation and measurement
  • Ambiguous or unconfirmed diagnosis of mitral regurgitation
  • Documented refusal to allow use of clinical or imaging data for research purposes
  • Missing essential clinical documentation required to confirm eligibility

Treatment and study plan

Primary outcomes

  1. Accuracy of AI-based semantic segmentation of mitral valve leaflets and MitraClip device components

    Time frame: Intraprocedural (TEE images acquired during the TEER procedure)

    The accuracy of the deep learning model in segmenting the anterior and posterior mitral leaflets, MitraClip grippers, and clip arms on intraprocedural transesophageal echocardiography (TEE) images. Performance is benchmarked against manual annotations provided by experienced echocardiographers and quantified using the Dice similarity coefficient, sensitivity, and specificity. Target performance: ≥ 90%.

  2. Accuracy of automated real-time recognition of mitral leaflet insertion length

    Time frame: Intraprocedural (TEE images acquired during the TEER procedure)

    The accuracy of the automated measurement system in recognizing the insertion length of the anterior and posterior mitral leaflets in two-dimensional TEE planes during the leaflet grasping process. Algorithm output is compared with manual measurements performed by experienced echocardiographers. Target performance: ≥ 95%.

Sponsors and collaborators

Lead sponsor

Mi Chen

Network

Collaborators

  • Chinese Academy of Medical Sciences, Fuwai Hospital
  • ETH Zurich (Switzerland)
  • Ospedale San Donato
  • San Raffaele University Hospital, Italy

Registry information

Official study title

Artificial Intelligence Semantic Segmentation Technology Assisting Transcatheter Mitral Edgeto-Edge Repair

Acronym: AutoClip

Important dates

Study start
2025
Primary completion
2026
Study completion
2030
First posted
Jun 8, 2026
Registry last updated
Jun 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.